5 years ago 1 min read U.S. drugmaker AbbVie Inc. and Chinese drug developer I-Mab agreed to collaborate on a cancer treatment in a deal that could be worth more than $2.9 billion. Continue Reading Previous How to recognize signs and symptoms of bipolar disorder in childrenNext 5 Easy, Practical Ways To Support Your Child’s Emotional Health This Year Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment Name * Email * Website Save my name, email, and website in this browser for the next time I comment. More Stories For Your Health 1 min read Record Korean Cases; Trader’s Guide to Rollout: Virus Update 5 years ago For Your Health 1 min read California Hits Record; Trader’s Guide to Rollout: Virus Update 5 years ago For Your Health 1 min read AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push 5 years ago
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push